Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Arthur Steinmetz Beteiligungs is a German holding and investment company that manages interests in various enterprises, with a significant focus on the healthcare and medical technology sectors. The company is notably associated with the ownership and strategic management of the Steinmetz Group, which operates specialized medical facilities and healthcare services. Its primary business involves the acquisition, management, and sale of corporate participations rather than direct drug discovery or biotechnology research. As a private investment vehicle, it plays a role in the consolidation and operational oversight of healthcare providers in Europe.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Arthur Steinmetz Beteiligungs.